Clinical Trial Update: Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vaccine therapy in combination with interleukin-2 and sargramostim in patients with advanced tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Cancer
• Gastric Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Vaccine Therapy (clinical trial)
• sargramostim (sargramostim)

Snippet

Sponsor: Georgetown University | Conditions: Breast Cancer, Esophageal Cancer | Phase 2 | Status: COMPLETED